Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Measles
SAGE documentation
Evidence to recommendation table
Clear all
Type of publications
SAGE documentation
(4)
Topics
Evidence to recommendation table
(4)
Regions
Countries
Diseases
COVID-19
(2)
Measles
(2)
Dengue
(2)
Diphtheria
(1)
Hepatitis B
(2)
Human papillomavirus (HPV)
(3)
Influenza
(1)
Malaria
(2)
Mpox // Monkeypox
(1)
Pertussis
(1)
Pneumococcal disease
(2)
Rabies
(2)
Rubella
(2)
Tuberculosis
(6)
Typhoid
(1)
Publication date
2022
(1)
2021
(1)
2017
(2)
Target population
Available to download in languages
English (EN)
(4)
4 results found
2022
∙
SAGE
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2021
∙
SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2017
∙
SAGE
Should SAGE recommend the removal of the criterion that MCV2 only be given if MCV1 coverage is >80% for the introduction of routine measles second dose as stated in the 2009 measles vaccine position paper?
2017
∙
SAGE
Should HIV-infected children receiving highly active antiretroviral therapy be revaccinated against measles?
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register